National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

cisplatin-e therapeutic implant
An injectable collagen matrix gel containing the inorganic platinum agent cisplatin and the sympathicomimetic agent epinephrine with potential antineoplastic activity. After intratumoral injection, cisplatin alkylates guanine nucleosides in DNA, and causes DNA-DNA or DNA-protein cross-linkages, thereby preventing DNA replication and resulting in tumor cell growth inhibition and apoptosis. Epinephrine, a potent vasoconstrictor, is added to the gel to enhance penetration of cisplatin into tumor tissue and reduce dispersion into the surrounding tissues. Intratumoral injection of cisplatin-E therapeutic implant may increase local chemotherapeutic efficacy compared to the systemic administration of these agents while reducing systemic toxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CDDP/epi gel
cisplatin/epinephrine gel
MPI 5010
US brand name:IntraDose
Abbreviation:CEG
Code name:MPI 5010



Previous:Cipro, ciprofloxacin, Circadin, cisplatin, cisplatin liposomal
Next:Cistane, citalopram hydrobromide, Citracal, Citroma, cladribine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov